Advertisement

Simple CT scan shows responsiveness to ovarian cancer treatment: Researchers

Dr. Ting-Yim Lee demonstrates the CT perfusion technology. Youtube

Researchers at Western University and Lawson Health Research Institute say a simple CT scanning procedure can show whether patients are responding to treatment for advanced ovarian cancer.

With help from his team at Robart Research Institute, Western University professor Ting-Yim Lee developed the CT perfusion technology, which measures blood flow and blood volume to ovarian cancer tumours.

“We’re looking at whether — before and after treatment — there is an increase in the blood flow in the ovarian cancer, or if there is a decrease,” Lee told AM980. He’s also a scientist at Lawson Health Research Institute and a medical physicist at St. Joseph’s Health Care London.

Receive the latest medical news and health information delivered to you every Sunday.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

READ MORE: Western University study shows promise for earlier dementia diagnoses

“What we found is that if there’s an increase in the blood flow four weeks into a treatment, then the patient would have a much shorter period where [they] would be symptom-free.”
Story continues below advertisement

This information allows an oncologist to determine whether a treatment plan is working, and allows them to change course if it isn’t. It would also spare a patient from unnecessary adverse effects.

The technology is already used globally to assess blood flow to the brain on patients who’ve had a stroke, and it’s easily implemented onto an existing CT scanner.

READ MORE: Western University students make their mark on Mars

While the results of the study — published in the journal Clinical Cancer Research — are promising, Lee said more research is necessary before the practice becomes a guideline.

“In order to gather more evidence so that it becomes a Level 1 evidence … you need other similarly designed trials to produce a similar effect.”

Lee says the technology has been in development in his lab for more than a decade.

The multi-centre clinical trial was funded by the US National Cancer Institute and took place at 19 centres in the United States.

Sponsored content

AdChoices